| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVS | Common Stock | Options Exercise | $2,875,430 | +49,279 | +7.9% | $58.35 | 675,552 | 28 Jun 2022 | Direct | |
| transaction | CVS | Common Stock | Sale | $4,681,505 | -49,279 | -7.3% | $95.00 | 626,273 | 28 Jun 2022 | Direct | F1 |
| transaction | CVS | Common Stock | Options Exercise | $2,736,703 | +50,502 | +8.1% | $54.19 | 676,775 | 28 Jun 2022 | Direct | |
| transaction | CVS | Common Stock | Sale | $4,797,690 | -50,502 | -7.5% | $95.00 | 626,273 | 28 Jun 2022 | Direct | F1 |
| transaction | CVS | Common Stock | Options Exercise | $2,888,264 | +38,873 | +6.2% | $74.30 | 665,146 | 28 Jun 2022 | Direct | |
| transaction | CVS | Common Stock | Sale | $3,692,935 | -38,873 | -5.8% | $95.00 | 626,273 | 28 Jun 2022 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVS | Stock Option | Options Exercise | $0 | -49,279 | -33% | $0.000000 | 98,558 | 28 Jun 2022 | Common Stock | 49,279 | $58.34 | Direct | F2, F3 |
| transaction | CVS | Stock Option | Options Exercise | $0 | -50,502 | -50% | $0.000000 | 50,502 | 28 Jun 2022 | Common Stock | 50,502 | $54.19 | Direct | F4 |
| transaction | CVS | Stock Option | Options Exercise | $0 | -38,873 | -25% | $0.000000 | 116,622 | 28 Jun 2022 | Common Stock | 38,873 | $74.30 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | All sales were effected pursuant to a Rule 10b5-1 plan. |
| F2 | The number of shares subject to the option were calculated using a 30-day average price. |
| F3 | Option became exercisable in four equal annual installments, commencing 4/1/2021. |
| F4 | Option became exercisable in four equal annual installments, commencing 4/1/2020. |
| F5 | Option became exercisable in four equal annual installments, commencing 4/1/2022. |